Intuitive Surgical, Inc. $ISRG Shares Purchased by Huntleigh Advisors Inc.

Huntleigh Advisors Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 97.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,152 shares of the medical equipment provider’s stock after purchasing an additional 1,061 shares during the quarter. Huntleigh Advisors Inc.’s holdings in Intuitive Surgical were worth $962,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vertex Planning Partners LLC grew its holdings in shares of Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after buying an additional 21 shares in the last quarter. City Holding Co. boosted its position in Intuitive Surgical by 16.1% during the second quarter. City Holding Co. now owns 159 shares of the medical equipment provider’s stock worth $86,000 after acquiring an additional 22 shares during the last quarter. True Vision MN LLC grew its stake in Intuitive Surgical by 3.0% during the 2nd quarter. True Vision MN LLC now owns 766 shares of the medical equipment provider’s stock valued at $416,000 after acquiring an additional 22 shares in the last quarter. Evermay Wealth Management LLC raised its holdings in Intuitive Surgical by 3.1% in the 2nd quarter. Evermay Wealth Management LLC now owns 731 shares of the medical equipment provider’s stock valued at $397,000 after acquiring an additional 22 shares during the last quarter. Finally, Avion Wealth raised its holdings in Intuitive Surgical by 2.3% in the 2nd quarter. Avion Wealth now owns 984 shares of the medical equipment provider’s stock valued at $534,000 after acquiring an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. Leerink Partners boosted their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Argus raised their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Royal Bank Of Canada lifted their price target on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Finally, BTIG Research reissued a “buy” rating and issued a $616.00 price objective (up previously from $589.00) on shares of Intuitive Surgical in a report on Wednesday, January 7th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $622.17.

Intuitive Surgical Trading Down 1.4%

Shares of NASDAQ:ISRG opened at $527.44 on Wednesday. The company has a market capitalization of $189.08 billion, a price-to-earnings ratio of 69.77, a PEG ratio of 4.35 and a beta of 1.67. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The business has a 50-day moving average price of $564.60 and a 200 day moving average price of $511.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the company posted $1.84 earnings per share. Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. This trade represents a 81.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This trade represents a 9.47% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.